ACR | Duration of | ||||
---|---|---|---|---|---|
Gender | Age | Criteria | RA (years) | Smoking | RA Tx |
M/F=4/9 | Avg = 52.7 Median=52 | ||||
F | 54 | Y | 4 | n | Sulfasalazine |
F | 63 | Y | 5 | n | TNF-alpha blocker |
F | 47 | Y | 10 | n | TNF-alpha blocker p ]Methotrexate Prednisone |
F | 55 | Y | 6 | n | TNF-alpha blocker Methotrexate Folic Acid |
F | 52 | Y | 17 | n | TNF-alpha blocker Methotrexate Folic Acid Hydroxychloroquine NSAIDS |
F | 38 | Y | 3 | n | Hydroxychloroquine |
M | 51 | Y | 16 | n | TNF-alpha blocker Prednisone |
F | 58 | Y | 10 | n | Hydroxychloroquine Prednisone |
M | 46 | Y | 16 | n | TNF-alpha blocker Methotrexate Folic Acid Prednisone |
F | 38 | Y | 10 | n | Methotrexate Prednisone NSAIDs |
F | 32 | Y | 5 | n | Sulfasalazine Methotrexate Folic Acid Prednisone |
M | 70 | Y | 31 | n | TNF-alpha blocker Methotrexate Folic Acid Prednisone |
M | 82 | Y | 3 | n | NSAIDs |